SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 125 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,349,035 | +61.9% | 247,076 | +196.4% | 0.00% | – |
| Q1 2024 | $833,470 | +212.9% | 83,347 | +27.7% | 0.00% | – |
| Q4 2023 | $266,355 | +19.5% | 65,283 | +13.3% | 0.00% | – |
| Q3 2023 | $222,892 | +80.2% | 57,595 | +52.3% | 0.00% | – |
| Q2 2023 | $123,664 | 0.0% | 37,818 | 0.0% | 0.00% | – |
| Q1 2023 | $123,664 | -40.5% | 37,818 | -28.1% | 0.00% | – |
| Q4 2022 | $207,841 | -99.9% | 52,618 | 0.0% | 0.00% | – |
| Q3 2022 | $315,708,000 | -32.4% | 52,618 | -27.5% | 0.00% | – |
| Q2 2022 | $466,818,000 | +129.7% | 72,600 | +195.1% | 0.00% | – |
| Q1 2022 | $203,196,000 | -46.6% | 24,600 | 0.0% | 0.00% | – |
| Q4 2021 | $380,808,000 | – | 24,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 25,001,856 | $96,757,183 | 7.02% |
| Omega Fund Management, LLC | 843,750 | $3,265,313 | 3.00% |
| Crestline Management, LP | 3,365,624 | $13,024,965 | 1.52% |
| Trustees of Columbia University in the City of New York | 98,353 | $380,626 | 0.70% |
| Alphabet Inc. | 2,812,500 | $10,884,375 | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,963,704 | $11,469,534 | 0.62% |
| Casdin Capital, LLC | 750,000 | $2,902,500 | 0.32% |
| PFM Health Sciences, LP | 1,244,139 | $4,814,818 | 0.23% |
| HARBOURVEST PARTNERS LLC | 137,694 | $532,876 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 540,250 | $2,091 | 0.18% |